Anthracyclines, such as doxorubicin, and monoclonal antibodies, such as trastuzumab, are compounds of wide clinical use as cytotoxic chemotherapy as they. Cardiotoxicidad asociada a trastuzumab en la práctica clínica asistencial Neutropenia inducida por dosis terapéuticas de metronidazol intravenoso. cardiotoxicidad inducida por quimioterapia, además de hacer una síntesis de los diferentes . tion (anthracyclines, trastuzumab, tyrosine kinase inhibitors.
|Published (Last):||2 May 2016|
|PDF File Size:||14.16 Mb|
|ePub File Size:||17.90 Mb|
|Price:||Free* [*Free Regsitration Required]|
Treatment and secondary prevention of venous thromboembolism in cancer.
There was a problem providing the content you requested
Characteristics and outcomes of patients with cancer requiring admission to intensive care units: Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: Risk factors for atrial fibrillation after lung cancer surgery: Services on Demand Article. Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia. Sunitinib versus interferon alfa cardiotoxicirad metastatic renal-cell carcinoma.
Early diagnosis of chemotherapy-induced cardiomyopathy: Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Doxorubicin and paclitaxel acrdiotoxicidad advanced breast carcinoma: What is QT interval prolongation? Docetaxel does not impair cardiac autonomic function in breast cancer patients previously treated with anthracyclines.
Muerte súbita debida a cardiotoxicidad aguda inducida por antraciclinas
However, the toxicity is a major adverse effect of these agents, which may occur at any time in their administration or afterwards, especially when used in combination. Bleomycin induced pulmonary toxicity: Korean J Intern Med.
Cardiovascular toxicity of some cancer agents others than anthracyclines, fluoropyrimidines and trastuzumab. Doxorubicin administration by continuous infusion is not cardioprotective: Results of the survival and ventricular enlargement trial.
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Optimal management of emergent hypertension during treatment with a VEGF signaling inhibitor: During the administration of the doses of Trastuzumab, three patients discontinued the use of the monoclonal antibody due to a decrease in the ejection fraction after the 6th, 7th and 10th cycles, one presented pulmonary thromboembolism after the 6th cycle, another presented dysuria after the 7th cycle, another patient had a seizure after the 12th cycle of Trastuzumab, in which an magnetic resonance imaging was performed on the skull showing the possibility of metastasis.
J Natl Compr Canc Netw.
Atrial fibrillation after thoracic surgery for lung dardiotoxicidad Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. Preventing postoperative pulmonary complications: Position statement on the use of bortezomib in multiple myeloma. Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies.
I Diretriz Brasileira de Cardio-Oncologia da Sociedade Brasileira de Cardiologia
Lapatinib and breast cancer: Reversibility of trastuzumab-related cardiotoxicity: Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy.
Periprocedural anticoagulation management of patients with traztuzumab thromboembolism. A cardiotoxicidade da ciclofosfamida pode apresentar-se de forma aguda ou subaguda 4. Because they are specific target drugs, few studies are concerned with evaluating these adverse events, which often makes clinical care difficult. Relationship between oxygen consumption and oxygen delivery during anesthesia in high-risk surgical patients.
J Cardiovasc Magn Reson.